Edition:
United States

Nate Raymond

Jeff Mason is a White House Correspondent for Reuters and the 2016-2017 president of the White House Correspondents’ Association. He was the lead Reuters correspondent for President Barack Obama's 2012 campaign and interviewed the president at the White House in 2015. Jeff has been based in Washington since 2008, when he covered the historic race between Obama, Hillary Clinton and John McCain. Jeff started his career in Frankfurt, Germany, where he covered the airline industry before moving to Brussels, Belgium, where he covered the European Union. He is a Colorado native, proud graduate of Northwestern University and former Fulbright scholar.

Twitter handle: @jeffmason1

May 24 2017

8th Circuit issues mixed ruling in gender reassignment coverage case

A federal appeals court on Wednesday ruled a Minnesota mother cannot sue her employer for discrimination for refusing to cover her son's gender reassignment treatment, but it revived related claims against her health plan administrator.

May 24 2017

Pfizer must face Lipitor injury lawsuits in California state court - judge

Pfizer Inc has lost a bid to remove from California state to federal court lawsuits by about 4,800 women who claim they developed diabetes as a result of taking the blockbuster anti-cholesterol drug Lipitor.

May 24 2017

New York's top court to weigh if doctors can assist suicide

New York's highest court will hear arguments next week on whether doctors can be prosecuted under state penal laws for prescribing medication that terminally ill patients could use to end their own lives.

May 24 2017

J&J settles drug manufacturing probe by U.S. states for $33 mln

Johnson & Johnson has agreed to pay $33 million to resolve charges by most U.S. states that it misrepresented the manufacturing practices behind Tylenol, Motrin, Benadryl and other over-the-counter drugs that were eventually recalled.

May 24 2017

J&J settles drug manufacturing probe by U.S. states for $33 million

Johnson & Johnson has agreed to pay $33 million to resolve charges by most U.S. states that it misrepresented the manufacturing practices behind several over-the-counter drugs that were eventually recalled.

May 24 2017

J&J settles drug manufacturing probe by U.S. states for $33 million

Johnson & Johnson has agreed to pay $33 million to resolve charges by most U.S. states that it misrepresented the manufacturing practices behind Tylenol, Motrin, Benadryl and other over-the-counter drugs that were eventually recalled.

May 23 2017

Consumer, health groups sue FDA over food additive rule

Several consumer and health groups have filed a lawsuit challenging a U.S. Food and Drug Administration rule they say will allow manufacturers to secretly decide what chemical additives are added to processed foods.

May 23 2017

Ex-Eaton Vance trader pleads guilty in U.S. to options fraud

BOSTON A former Eaton Vance Corp portfolio manager pleaded guilty on Tuesday to an illegal options trading scheme that defrauded the company and allowed him to make $1.9 million in profits.

May 23 2017

Ex-Eaton Vance trader pleads guilty in U.S. to options fraud

BOSTON A former Eaton Vance Corp portfolio manager pleaded guilty on Tuesday to an illegal options trading scheme that defrauded the company and allowed him to make $1.9 million in profits.

May 22 2017

Judge limits Apotex damages in Provigil pay-for-delay lawsuit

A federal judge has limited the amount of damages Apotex Inc may seek in a lawsuit accusing drugmakers Mylan Inc and Ranbaxy Laboratories Ltd of accepting payments from Cephalon Inc to delay generic versions of its wakefulness drug Provigil.

More From Around the Web

Markets

  • U.S.
  • Europe
  • Asia
  • Sectors

Sector Summary